Derivatix Quarterly Report: 2022-Q1 as of Mar. 31st, 2022
Happy spring to all who have been waiting long for outdoor activities…. 2022-Q1 Market Summary*: U.S. equities closed out their...
Derivatix Quarterly Report: 2021-Q4 as of Dec. 31st, 2021
2021-Q4 Market Summary*: It was a wild year in many respects, but the stock market turned in a solid performance...
Derivatix Quarterly Report: 2021-Q2 as of Sep. 30th, 2021
As we are getting more and more into the beautiful fall, we would like to take this opportunity to wish...
Derivatix Quarterly Report: 2021-Q2 as of Jun. 30th, 2021
2021-Q2 Market Summary*: U.S. equity benchmarks closed the first half of 2021 at or near record highs as the economy...
Derivatix Quarterly Report: 2021-Q1 as of Mar. 30th, 2021
2020-Q4 Market Summary*: Efficient U.S. vaccination distribution, $1.9 trillion in fiscal stimulus, and a proposed $2 trillion infrastructure bill are...
Derivatix Quarterly Report: Mid 2021-Q1 as of Feb. 16th 2021
2021-Q1 Market Summary*: U.S. equities reversed losses and staged a rally as Federal Reserve Chairman Jerome Powell reaffirmed his view...
Derivatix Info Session Mar. 7th 2021
Most people think that successful traders are all really smart. Like high IQ smart. I am talking about an IQ...
Derivatix Quarterly Report: 2020-Q4 as of Dec. 31st, 2020
2020-Q4 Market Summary*: 2020 was a year of surprises. There was the speed at which the pandemic escalated, the severity...
Derivatix Quarterly Report: Mid 2020-Q4 as of Nov. 13th 2020
2020-Q4 Market Summary: The US election, as the major event of Q4, is now behind us. The market reacted positively...
Derivatix Quarterly Report: 2020-Q3 as of Sep. 30th 2020
After a devastating 1st quarter for the global, market, followed by a 2nd quarter recovery on the back of heavy...
Recent Comments